A large-scale study has surfaced a troubling signal in one of medicine's most familiar tools: a commonly prescribed antibiotic, long considered a reliable first-line defense against bacterial infection, now appears linked to elevated mortality in adult patients. The finding does not overturn what the drug does well, but it complicates the quiet confidence with which it has been routinely administered. Medicine has always carried the tension between the harm of the disease and the harm of the cure, and this study has placed that tension, once again, at the center of clinical practice.
Major Study Links Common Antibiotic to Increased Mortality Risk in Adults
The study indicates increased mortality risk in adults treated with this antibiotic, though specific casualty numbers are not provided in the available information.